Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Cells ; 12(20)2023 10 11.
Article in English | MEDLINE | ID: mdl-37887275

ABSTRACT

TAZ (WWTR1) is a transcriptional co-activator regulated by Hippo signaling, mechano-transduction, and G-protein couple receptors. Once activated, TAZ and its paralogue, YAP1, regulate gene expression programs promoting cell proliferation, survival, and differentiation, thus controlling embryonic development, tissue regeneration, and aging. YAP and TAZ are also frequently activated in tumors, particularly in poorly differentiated and highly aggressive malignancies. Yet, mutations of YAP/TAZ or of their upstream regulators do not fully account for their activation in cancer, raising the possibility that other upstream regulatory pathways, still to be defined, are altered in tumors. In this work, we set out to identify novel regulators of TAZ by means of a siRNA-based screen. We identified 200 genes able to modulate the transcriptional activity of TAZ, with prominence for genes implicated in cell-cell contact, cytoskeletal tension, cell migration, WNT signaling, chromatin remodeling, and interleukins and NF-kappaB signaling. Among these genes we identified was BRCC3, a component of the BRCA1 complex that guards genome integrity and exerts tumor suppressive activity during cancer development. The loss of BRCC3 or BRCA1 leads to an increased level and activity of TAZ. Follow-up studies indicated that the cytoplasmic BRCA1 complex controls the ubiquitination and stability of TAZ. This may suggest that, in tumors, inactivating mutations of BRCA1 may unleash cell transformation by activating the TAZ oncogene.


Subject(s)
Neoplasms , Trans-Activators , Humans , Trans-Activators/genetics , Trans-Activators/metabolism , YAP-Signaling Proteins , Intracellular Signaling Peptides and Proteins/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Wnt Signaling Pathway , BRCA1 Protein/genetics , BRCA1 Protein/metabolism , Deubiquitinating Enzymes/metabolism
2.
EMBO Rep ; 22(2): e51184, 2021 02 03.
Article in English | MEDLINE | ID: mdl-33410591

ABSTRACT

Differentiation of naïve peripheral B cells into terminally differentiated plasma cells is characterized by epigenetic alterations, yet the epigenetic mechanisms that control B-cell fate remain unclear. Here, we identified a role for the histone H3K79 methyltransferase DOT1L in controlling B-cell differentiation. Mouse B cells lacking Dot1L failed to establish germinal centers (GC) and normal humoral immune responses in vivo. In vitro, activated B cells in which Dot1L was deleted showed aberrant differentiation and prematurely acquired plasma cell characteristics. Similar results were obtained when DOT1L was chemically inhibited in mature B cells in vitro. Mechanistically, combined epigenomics and transcriptomics analysis revealed that DOT1L promotes expression of a pro-proliferative, pro-GC program. In addition, DOT1L indirectly supports the repression of an anti-proliferative plasma cell differentiation program by maintaining the repression of Polycomb Repressor Complex 2 (PRC2) targets. Our findings show that DOT1L is a key modulator of the core transcriptional and epigenetic landscape in B cells, establishing an epigenetic barrier that warrants B-cell naivety and GC B-cell differentiation.


Subject(s)
B-Lymphocytes/cytology , Cell Differentiation , Histone-Lysine N-Methyltransferase , Histones , Methyltransferases , Animals , Epigenesis, Genetic , Histone-Lysine N-Methyltransferase/genetics , Histones/genetics , Histones/metabolism , Methyltransferases/genetics , Methyltransferases/metabolism , Mice
3.
J Exp Med ; 217(10)2020 10 05.
Article in English | MEDLINE | ID: mdl-32609329

ABSTRACT

The establishment of protective humoral immunity is dependent on the ability of mature B cells to undergo antibody gene diversification while adjusting to the physiological stressors induced by activation with the antigen. Mature B cells diversify their antibody genes by class switch recombination (CSR) and somatic hypermutation (SHM), which are both dependent on efficient induction of activation-induced cytidine deaminase (AID). Here, we identified PDGFA-associated protein 1 (Pdap1) as an essential regulator of cellular homeostasis in mature B cells. Pdap1 deficiency leads to sustained expression of the integrated stress response (ISR) effector activating transcription factor 4 (Atf4) and induction of the ISR transcriptional program, increased cell death, and defective AID expression. As a consequence, loss of Pdap1 reduces germinal center B cell formation and impairs CSR and SHM. Thus, Pdap1 protects mature B cells against chronic ISR activation and ensures efficient antibody diversification by promoting their survival and optimal function.


Subject(s)
Antibody Diversity , B-Lymphocytes/metabolism , Genes, Immunoglobulin/genetics , Animals , B-Lymphocytes/immunology , CRISPR-Associated Protein 9 , CRISPR-Cas Systems , Cell Death , Cell Differentiation , Cell Line , Female , Fluorescent Antibody Technique , Gene Editing , Gene Expression Regulation , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic
4.
Life Sci Alliance ; 3(6)2020 06.
Article in English | MEDLINE | ID: mdl-32341085

ABSTRACT

The major function of B lymphocytes is to sense antigens and to produce protective antibodies after activation. This function requires the expression of a B-cell antigen receptor (BCR), and evolutionary conserved mechanisms seem to exist that ensure that B cells without a BCR do not develop nor survive in the periphery. Here, we show that the loss of BCR expression on Burkitt lymphoma cells leads to decreased mitochondrial function and impaired metabolic flexibility. Strikingly, this phenotype does not result from the absence of a classical Syk-dependent BCR signal but rather from compromised ER expansion. We show that the reexpression of immunoglobulins (Ig) in the absence of the BCR signaling subunits Igα and Igß rescues the observed metabolic defects. We demonstrate that immunoglobulin expression is needed to maintain ER homeostasis not only in lymphoma cells but also in resting B cells. Our study provides evidence that the expression of BCR components, which is sensed in the ER and shapes mitochondrial function, represents a novel mechanism of metabolic control in B cells.


Subject(s)
B-Lymphocytes/metabolism , Burkitt Lymphoma/metabolism , Endoplasmic Reticulum/immunology , Immunoglobulin M/metabolism , Signal Transduction/genetics , Animals , Burkitt Lymphoma/pathology , Cell Line, Tumor , Gene Knockout Techniques , Homeostasis/genetics , Homeostasis/immunology , Humans , Immunoglobulin M/genetics , Mice , Mice, Transgenic , Mitochondria/metabolism , Phenotype , Receptors, Antigen, B-Cell/genetics , Receptors, Antigen, B-Cell/metabolism , Signal Transduction/immunology , Syk Kinase/deficiency , Syk Kinase/genetics , Transduction, Genetic
6.
Genes Dev ; 31(20): 2017-2022, 2017 10 15.
Article in English | MEDLINE | ID: mdl-29141911

ABSTRACT

Mammalian cells must integrate environmental cues to determine coherent physiological responses. The transcription factors Myc and YAP-TEAD act downstream from mitogenic signals, with the latter responding also to mechanical cues. Here, we show that these factors coordinately regulate genes required for cell proliferation. Activation of Myc led to extensive association with its genomic targets, most of which were prebound by TEAD. At these loci, recruitment of YAP was Myc-dependent and led to full transcriptional activation. This cooperation was critical for cell cycle entry, organ growth, and tumorigenesis. Thus, Myc and YAP-TEAD integrate mitogenic and mechanical cues at the transcriptional level to provide multifactorial control of cell proliferation.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Cell Proliferation/genetics , Phosphoproteins/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Transcriptional Activation , Adaptor Proteins, Signal Transducing/genetics , Animals , Cell Cycle/genetics , Cell Cycle Proteins , Cells, Cultured , Intercellular Signaling Peptides and Proteins/physiology , Mechanotransduction, Cellular , Mice , Mice, Transgenic , Phosphoproteins/genetics , Signal Transduction , Transcription Factors/metabolism , YAP-Signaling Proteins
7.
J Clin Invest ; 123(12): 5009-22, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24200695

ABSTRACT

Protection against deadly pathogens requires the production of high-affinity antibodies by B cells, which are generated in germinal centers (GCs). Alteration of the GC developmental program is common in many B cell malignancies. Identification of regulators of the GC response is crucial to develop targeted therapies for GC B cell dysfunctions, including lymphomas. The histone H3 lysine 27 methyltransferase enhancer of zeste homolog 2 (EZH2) is highly expressed in GC B cells and is often constitutively activated in GC-derived non-Hodgkin lymphomas (NHLs). The function of EZH2 in GC B cells remains largely unknown. Herein, we show that Ezh2 inactivation in mouse GC B cells caused profound impairment of GC responses, memory B cell formation, and humoral immunity. EZH2 protected GC B cells against activation-induced cytidine deaminase (AID) mutagenesis, facilitated cell cycle progression, and silenced plasma cell determinant and tumor suppressor B-lymphocyte-induced maturation protein 1 (BLIMP1). EZH2 inhibition in NHL cells induced BLIMP1, which impaired tumor growth. In conclusion, EZH2 sustains AID function and prevents terminal differentiation of GC B cells, which allows antibody diversification and affinity maturation. Dysregulation of the GC reaction by constitutively active EZH2 facilitates lymphomagenesis and identifies EZH2 as a possible therapeutic target in NHL and other GC-derived B cell diseases.


Subject(s)
B-Lymphocytes/immunology , Germinal Center/enzymology , Lymphoma, Non-Hodgkin/etiology , Polycomb Repressive Complex 2/physiology , Animals , Apoptosis , B-Lymphocytes/pathology , Cell Cycle , Cytidine Deaminase/deficiency , Cytidine Deaminase/genetics , Cytidine Deaminase/physiology , DNA Damage , Enhancer of Zeste Homolog 2 Protein , Enzyme Activation , Gene Expression Regulation, Neoplastic , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Gene Silencing , Germinal Center/immunology , Germinal Center/pathology , Immunity, Humoral , Immunologic Memory , Lymphoma, Non-Hodgkin/enzymology , Lymphoma, Non-Hodgkin/genetics , Lymphoma, Non-Hodgkin/pathology , Lymphopoiesis , Methylation , Mice , Mice, Transgenic , Polycomb Repressive Complex 2/deficiency , Polycomb Repressive Complex 2/genetics , Positive Regulatory Domain I-Binding Factor 1 , Protein Processing, Post-Translational , Transcription Factors/physiology
8.
Cell Rep ; 2(5): 1244-58, 2012 Nov 29.
Article in English | MEDLINE | ID: mdl-23103168

ABSTRACT

JMJD3 (KDM6B) antagonizes Polycomb silencing by demethylating lysine 27 on histone H3. The interplay of methyltransferases and demethylases at this residue is thought to underlie critical cell fate transitions, and the dynamics of H3K27me3 during neurogenesis posited for JMJD3 a critical role in the acquisition of neural fate. Despite evidence of its involvement in early neural commitment, however, its role in the emergence and maturation of the mammalian CNS remains unknown. Here, we inactivated Jmjd3 in the mouse and found that its loss causes perinatal lethality with the complete and selective disruption of the pre-Bötzinger complex (PBC), the pacemaker of the respiratory rhythm generator. Through genetic and electrophysiological approaches, we show that the enzymatic activity of JMJD3 is selectively required for the maintenance of the PBC and controls critical regulators of PBC activity, uncovering an unanticipated role of this enzyme in the late structuring and function of neuronal networks.


Subject(s)
Jumonji Domain-Containing Histone Demethylases/metabolism , Neurons/metabolism , Animals , Cell Line , Embryo, Mammalian/metabolism , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Histones/metabolism , Jumonji Domain-Containing Histone Demethylases/deficiency , Jumonji Domain-Containing Histone Demethylases/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Perinatal Mortality , Respiratory Burst/physiology , Respiratory Insufficiency/pathology , Somatostatin/metabolism
9.
Pharmacol Biochem Behav ; 101(1): 85-7, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22197713

ABSTRACT

Testosterone affects behavior. Whether regular physical training does influence these effects is unknown. The assumption that testosterone induces muscular hypertrophy if combined with physical training has not been confirmed experimentally. The aim of this study was to evaluate whether activity and/or testosterone treatment affects depression-like behavior and to observe the effects of activity and testosterone on muscle fiber diameter. Forty-three male rats were divided into 4 groups: two groups (TST act and TST lazy) were treated with testosterone (5mg/kg) and two groups were used as control (CTRL act and CTRL lazy). Two of the groups (CTRL act and TST act) underwent 2weeks of exercise. The forced swim test was used as a test of depression-like behavior. Sex steroids were measured and the diameter of skeletal muscle fibers was evaluated. Testosterone was significantly higher in both testosterone-treated groups (p<0.001). Physically active groups had higher immobility times in the forced swim test than inactive groups. Groups CTRL act and TST lazy showed significantly larger diameter of muscle fibers in comparison to the TST act group. Our results suggest that physical activity induces depression-like behavior in rats. Controversial antagonistic effects of testosterone and physical activity on muscle fiber diameter were found.


Subject(s)
Behavior, Animal/physiology , Depression/psychology , Physical Conditioning, Animal/psychology , Analysis of Variance , Animals , Behavior, Animal/drug effects , Cell Size/drug effects , Estradiol/blood , Male , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/physiology , Muscle Fibers, Skeletal/ultrastructure , Progesterone/blood , Rats , Rats, Wistar , Swimming/psychology , Testosterone/blood , Testosterone/pharmacology
10.
EMBO J ; 28(21): 3341-52, 2009 Nov 04.
Article in English | MEDLINE | ID: mdl-19779457

ABSTRACT

Jmjd3, a JmjC family histone demethylase, is induced by the transcription factor NF-kB in response to microbial stimuli. Jmjd3 erases H3K27me3, a histone mark associated with transcriptional repression and involved in lineage determination. However, the specific contribution of Jmjd3 induction and H3K27me3 demethylation to inflammatory gene expression remains unknown. Using chromatin immunoprecipitation-sequencing we found that Jmjd3 is preferentially recruited to transcription start sites characterized by high levels of H3K4me3, a marker of gene activity, and RNA polymerase II (Pol_II). Moreover, 70% of lipopolysaccharide (LPS)-inducible genes were found to be Jmjd3 targets. Although most Jmjd3 target genes were unaffected by its deletion, a few hundred genes, including inducible inflammatory genes, showed moderately impaired Pol_II recruitment and transcription. Importantly, most Jmjd3 target genes were not associated with detectable levels of H3K27me3, and transcriptional effects of Jmjd3 absence in the window of time analysed were uncoupled from measurable effects on this histone mark. These data show that Jmjd3 fine-tunes the transcriptional output of LPS-activated macrophages in an H3K27 demethylation-independent manner.


Subject(s)
Gene Expression Regulation , Jumonji Domain-Containing Histone Demethylases/metabolism , Lipopolysaccharides/immunology , Macrophage Activation , Macrophages/immunology , Animals , Cells, Cultured , Female , Gene Knockout Techniques , Jumonji Domain-Containing Histone Demethylases/analysis , Jumonji Domain-Containing Histone Demethylases/genetics , Macrophages/metabolism , Mice
11.
Gynecol Obstet Invest ; 59(2): 62-6, 2005.
Article in English | MEDLINE | ID: mdl-15528926

ABSTRACT

BACKGROUND: Soy phytoestrogens are known to influence the hormonal status acting as partial estrogen agonists. Soy-derived food supplements are advised for hormone replacement therapy, prevention of atherosclerosis, age-related cognitive decline and even hormone-dependent cancer, although results from clinical studies are controversial. Whether increased soybean intake can affect the endocrine status and cognitive abilities is largely unknown. AIM: To observe the effects of 1 week of increased soybean intake on sex hormone levels and spatial cognitive abilities in women. SUBJECTS AND METHODS: 16 young healthy female volunteers were asked to eat 900 g of soybeans within 1 week. Salivary testosterone (T), free and total plasma T, salivary and plasma estradiol (E) were measured by radioimmunoassay before and after the study period. Mental rotation (MR) and spatial visualization (SV) psychological tests were done at the days of sampling. RESULTS: Soybean intake increased total plasma T levels (p < 0.02) while decreasing salivary T (p < 0.01) and not altering free plasma T levels. Salivary and plasma E levels were not changed. The results of MR and SV tests were improved after the study period. CONCLUSION: Short-time increased soybean intake alters the level of total plasma and salivary T and improves spatial cognition in women. Whether this effect is mediated by modulation of estrogen receptors, changes in sex hormone-binding globulin production or changes in activity of steroid-competent enzymes needs further study.


Subject(s)
Cognition/drug effects , Dietary Supplements/supply & distribution , Estradiol/metabolism , Glycine max/metabolism , Testosterone/metabolism , Adult , Estradiol/blood , Female , Humans , Psychological Tests , Radioimmunoassay , Testosterone/blood , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...